Posted in | News | Nanofluidics

Joint Research Agreement to Advance the Development of Microfluidics Technology

Singapore Institute of Manufacturing Technology (SIMTech), a research institute of the Agency for Science, Technology and Research (A*STAR), announced the signing of a Memorandum of Understanding with the Centre Suisse d'Electronique et de Microtechnique SA (CSEM), Switzerland, to carry out joint research projects and facilitate the exchange of research and scientific staff members to advance the development of microfluidics technology.

Microfluidics technology has been adopted for increasingly diverse use in ink-jet printing, lab-on-a-chip, biomedical research and diagnostics, chemical processing, water monitoring and the harnessing of alternative energy. According to Yole Development (EMMA2007), the potential market size of microfluidics technology in life science alone will be about US$2 billion in 2012. Advances in microfluidics technology are well aligned with Singapore's long-term R&D thrusts to grow the strategic clean energy, water, environment and biomedical industries.

The three-year collaboration between the institutes of the two countries will build upon the collective and complementary research capabilities in microfluidics technology and microsystem technology of SIMTech and CSEM, respectively. The proposed research collaboration areas will cover microsystem technology, environmental monitoring, microfluidics and lab-on-a-chip developments.

One specific collaborative effort is on the development of a microfluidic platform for environmental quality monitoring to detect impurities and contaminants in water. In this project, CSEM will spearhead the microsystem development and SIMTech will focus on coming up with innovative polymer microfluidics for the manipulation of liquid samples.

Another area for collaboration is on the realisation of an integrated biochip system for disease detection. With CSEM's extensive expertise in ISFET (ion sensitive field effect transistor) and SIMTech's polymer microfluidics design and manufacturing experience for sample preparation, a self-contained and fully integrated biochip system will be developed. The system can potentially be used for medical diagnostic applications. The progressive shift from traditional laboratory processes to the portable lab-on-a-chip offers many advantages such as improved performance in speed, reproducibility, reduced cost and reagents consumption, lower contamination and operator error, and the convenience of more parallel and integrated analyses.

“The multi-disciplinary joint collaboration drawing on the strengths of both institutes will accelerate the advancement of microfluidics technology. The accelerated development will enable the clean energy, environment, water and biomedical industries to leverage on the outcomes and achievements for a clear competitive advantage. More importantly, the joint multi-disciplinary microfluidics development offers the industry microfluidics solutions in an integrated platform“ commented Dr Lim Ser Yong, Executive Director, SIMTech.

“SIMTech and CSEM have already worked together for a long time, and it is a great pleasure for us to intensify this collaboration in a field of high strategic value and high commercial interest, especially for all issues concerning microsystems technologies. CSEM and SIMTech together will be able to push the boundaries of the technology in this area, ” said Prof Thomas Hinderling, CEO, CSEM.

The genesis of this collaboration started through the A*STAR Visiting Investigatorship Programme (VIP). Prof Nico de Rooij, the Institute Director of Ecole Polytechnique Federale De Lausane, Head of Sensors, Actuators and Microsystems Lab (SAMLab) and Vice-President, Microsystems Technology, CSEM, was the A*STAR Visiting Investigator for the development of a re-configurable integration platform, encompassing fluidic and electronic components for potential applications in biomedical, chemical analysis, power and drop ejections.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.